+13%

est. 2Y upside i

AI & MLSeries B

We build AI agents that can reason and code—imbuing computers with intelligence and human values so they can help us accomplish larger goals in the world. To do this, we train foundation models optimized for reasoning.

Rank

#3201

Sector

Artificial Intelligence

Est. Liquidity

~3Y

Data Quality

Data: Medium

Imbue presents a risky equity opportunity with a low expected upside, primarily due to intense competition from dominant AI incumbents and a high capital intensity business model.

Last updated: March 10, 2026

Bull (15%)+200%

Imbue's newly launched 'Vet' code review tool gains significant traction, and the company successfully launches other highly differentiated AI agents for complex reasoning and coding tasks, carving out a strong niche in the developer tools market. This leads to rapid revenue growth and a successful Series C/D funding round, pushing the valuation to $3.0B.

Base (35%)+50%

Imbue continues to develop its AI agents, with moderate adoption of 'Vet' and other early products. The company faces intense competition from incumbents, limiting market share expansion. Imbue secures another funding round, but valuation growth is modest, reaching approximately $1.5B.

Bear (50%)-70%

Imbue struggles to differentiate its products against rapidly evolving incumbent offerings from OpenAI, Google, and Microsoft, which integrate advanced coding and reasoning agents directly into their platforms. 'Vet' sees limited adoption, and future product launches are delayed or fail to gain significant traction. The high burn rate leads to a down round or acquisition at a significantly reduced valuation, potentially $300M, wiping out most common-stock value given substantial liquidation preferences.

Est. time to liquidity~3.0 years

Preference Stack Risk

high

Funding Intensity

23%

Investors hold at least $232 million in liquidation preferences ahead of common stock, meaning common shareholders may receive little or nothing in an exit at or below this amount.

Dilution Risk

high

As a Series B company with high capital intensity and a newly launched product, additional funding rounds are highly probable, leading to further dilution for existing equity holders.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for Imbue's equity at this time.

Other — 3 roles

View all 3 open roles at Imbue →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Imbue's data — designed to show you've done your homework.

  • 1

    “With the recent launch of Vet, how is Imbue planning to differentiate its coding agents and reasoning models from the rapidly evolving offerings of incumbents like OpenAI's GPT-4 and Google's Gemini, particularly in terms of market adoption and pricing power?”

  • 2

    “Given the high capital intensity of training foundation models and the stated long commercialization timeline, what are the key milestones and revenue generation strategies Imbue aims to achieve over the next 24 months to ensure a healthy runway and future funding rounds?”

  • 3

    “Considering the $232 million in total funding and the $1 billion valuation, how does Imbue communicate the potential impact of liquidation preferences to employees, and what are the company's plans for providing any form of secondary liquidity in the future?”

Community

Valuation Sentiment

Our model estimates +13% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.